Analytica Bio Energy Corp Stock Price To Earning
Analytica Bio Energy Corp fundamentals help investors to digest information that contributes to Analytica Bio's financial success or failures. It also enables traders to predict the movement of Analytica Stock. The fundamental analysis module provides a way to measure Analytica Bio's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Analytica Bio stock.
Analytica |
Analytica Bio Energy Corp Company Price To Earning Analysis
Analytica Bio's Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.
Current Analytica Bio Price To Earning | 0.35 X |
Most of Analytica Bio's fundamental indicators, such as Price To Earning, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Analytica Bio Energy Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Generally speaking, the Price to Earnings ratio gives investors an idea of what the market is willing to pay for the company's current earnings.
CompetitionBased on the latest financial disclosure, Analytica Bio Energy Corp has a Price To Earning of 0.35 times. This is much higher than that of the sector and significantly higher than that of the Price To Earning industry. The price to earning for all United States stocks is notably lower than that of the firm.
Analytica Price To Earning Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Analytica Bio's direct or indirect competition against its Price To Earning to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Analytica Bio could also be used in its relative valuation, which is a method of valuing Analytica Bio by comparing valuation metrics of similar companies.Analytica Bio is currently under evaluation in price to earning category among its peers.
Analytica Fundamentals
| Return On Equity | -16.3 | |||
| Return On Asset | -195.14 | |||
| Profit Margin | 311.56 % | |||
| Operating Margin | (49.59) % | |||
| Current Valuation | 536.46 K | |||
| Shares Outstanding | 29.18 M | |||
| Price To Earning | 0.35 X | |||
| Price To Sales | 1.15 X | |||
| Revenue | 202.5 K | |||
| Gross Profit | 62.91 K | |||
| EBITDA | (95.25 K) | |||
| Net Income | 630.92 K | |||
| Cash And Equivalents | 13.74 K | |||
| Total Debt | 316.75 K | |||
| Debt To Equity | 0.07 % | |||
| Current Ratio | 0.31 X | |||
| Book Value Per Share | (0.01) X | |||
| Cash Flow From Operations | 138.73 K | |||
| Earnings Per Share | 0.02 X | |||
| Beta | 3.32 | |||
| Market Capitalization | 233.44 K | |||
| Total Asset | 400 K | |||
| Retained Earnings | (4.68 M) | |||
| Working Capital | (556 K) | |||
| Current Asset | 249 K | |||
| Current Liabilities | 805 K | |||
| Z Score | -16.6 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Other Consideration for investing in Analytica Stock
If you are still planning to invest in Analytica Bio Energy check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Analytica Bio's history and understand the potential risks before investing.
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Fundamental Analysis View fundamental data based on most recent published financial statements |